321 – 330 of 382
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Functional characterization of Factor V-Ile359Thr, a novel mutation associated with thrombosis.
- Contribution to journal › Article
-
Mark
Enforced expression of cyclin D2 enhances the proliferative potential of myeloid progenitors, accelerates in vivo myeloid reconstitution, and promotes rescue of mice from lethal myeloablation.
- Contribution to journal › Article
-
Mark
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
- Contribution to journal › Article
-
Mark
Overexpression of CXCR4 on human CD34(+) progenitors increases their proliferation, migration, and NOD/SCID repopulation
- Contribution to journal › Article
-
Mark
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
- Contribution to journal › Article
-
Mark
Stem cell expansion: success and complexities
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells
- Contribution to journal › Article
-
Mark
Anticoagulant factor V and thrombosis risk
- Contribution to journal › Debate/Note/Editorial
- 2003
-
Mark
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
- Contribution to journal › Article
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
- Contribution to journal › Article
